苏州地区儿童社区获得性肺炎116例临床分析  

Clinical analysis of 116 children with community-acquired pneumonia in Suzhou

作　　者：赵凯[1] 何丽萍[1] 包丽丽[1] 

机构地区：[1]苏州市立医院(南京医科大学附属苏州医院)本部儿科,江苏苏州215002

出　　处：《中国中西医结合儿科学》2015年第6期566-568,共3页Chinese Pediatrics of Integrated Traditional and Western Medicine

摘　　要：目的分析苏州地区儿童社区获得性肺炎(CAP)的临床特征。方法苏州市立医院本部儿科2013-07/09收治116例CAP患儿,将其详实的临床资料加以分析。结果 116例CAP患儿中胸部影像学检查显示为支气管肺炎者93例,显示为大叶性肺炎者23例,两组比较大叶性肺炎组患儿平均年龄大、住院时间长、发热率高、支原体感染率高,经检验组间差异有统计学意义(P<0.05);两组性别、湿啰音、哮鸣音、腹泻、白细胞计数、丙氨酸氨基转移酶、天门冬氨酸氨基转移酶、心肌型肌酸激酶同功酶组间比较差异无统计学意义(P>0.05)。结论儿童是CAP的易感人群,临床表现复杂而又缺乏特异性,须警惕肺炎支原体等非典型微生物感染,需关注病程中心肌损伤的程度。临床需要提高认知,加强研究,早期诊断,合理治疗,改善预后,进而和谐医患关系。Objective To analyze the clinical features of community-acquired pneumonia（CAP）in children in Suzhou.Methods A total of 116 children with CAP were selected and the clinical data were analyzed.Results Among the 116 cases,93cases were diagnosed as bronchial pneumonia and 23 cases were diagnosed as lobar pneumonia by using chest radiographic examination.Patients diagnosed with lobar pneumonia showed higher average age,longer hospitalization time,higher fever ratio（95.65%）,and higher mycoplasma infection rate（86.96%）;there was significant difference between the two groups（P〈0.05）;however,no significant difference was found among gender,clinical manifestations（the moist rale,wheezing and diarrhea）,laboratory tests（white blood cell,alanine transaminase,aspartate amino transferase and myocardial creatine kinase isoenzyme）between the two groups（P〉0.05）.Conclusion Children are susceptible to CAP.However,the clinical manifestations are complicated and lack of specificity.We must be alert to atypical microbial infections such as mycoplasma pneumoniae,and pay great attention to the degree of myocardial injury during the course of the disease.Therefore,efforts should be made to improve clinical cognition,to strengthen research,to obtain early diagnosis and reasonable treatment,to improve prognosis,and then to promote the harmonious relationship between doctors and patients.

关 键 词：社区获得性肺炎 临床特征 儿童 

分 类 号：R563.1[医药卫生—呼吸系统]